TrialBMC cancer2015

Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Anastasia S Proskurina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.